Testing version — LOERadar is in active testing. Features and data may change.
RIFAMPIN (RIFAMPIN) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
RIFAMPIN
ANDANot in Orange Book
RIFAMPIN | A219918 | NOVITIUM PHARMA
Products (2)
Sort:
#001 — 150MG
▴
CAPSULE;ORAL | Approved: Jun. 29, 2026
No patent or exclusivity listings for this strength.